2006
DOI: 10.1007/s11224-006-9008-2
|View full text |Cite
|
Sign up to set email alerts
|

Paradigms and paradoxes: Mechanisms for possible enhanced biological activity of bilaterally symmetrical chemicals

Abstract: We propose a mechanism that bilateral symmetry yields an entropic advantage for enzyme recognition. We suggest that bilateral symmetry may be a guiding principle used by nature to produce some particularly effective receptor-ligand interactions. An essential result is that bilateral symmetry is common among enzyme inhibitors, which coupled with an enhanced bond energy that connects dimer molecules compared to a reduced bond energy profile for higher oligomers provides a clue to explain the abundance of bilater… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 5 publications
1
7
0
Order By: Relevance
“…For example, natural compounds with bilateral symmetry are more frequently enzyme inhibitors (22%) in comparison with nonsymmetrical natural compound (8%). 32 The inhibitory characteristics of the scaffolds we identified are comparable with those selected by others. The existing WNV and DV NS2B-NS3 inhibitors are predominantly peptide based and they target directly the active site of the NS3pro domain.…”
Section: Discussionsupporting
confidence: 78%
“…For example, natural compounds with bilateral symmetry are more frequently enzyme inhibitors (22%) in comparison with nonsymmetrical natural compound (8%). 32 The inhibitory characteristics of the scaffolds we identified are comparable with those selected by others. The existing WNV and DV NS2B-NS3 inhibitors are predominantly peptide based and they target directly the active site of the NS3pro domain.…”
Section: Discussionsupporting
confidence: 78%
“…Our interest to study the biosynthesis of 1 was inspired by its intriguing structural features, which hinted that it is biosynthesized by a nonribosomal peptide synthetase (NRPS) assembly line, followed by post‐NRPS modifications including oxygenation of the L ‐Trp residue to a hexahydropyrroloindole subunit and subsequent symmetrical biaryl coupling. Many complex natural products are symmetric dimers formed through a biaryl linkage, usually biologically superior to those of their monomers 8. Enzymes involved in biaryl natural product formation through oxidative phenol coupling have been reported;9 however, the exact enzymatic reaction catalyzing this regioselective oxidative carbon–carbon coupling reaction is poorly understood.…”
Section: Methodsmentioning
confidence: 99%
“…Many complex natural products are symmetric dimers formed through a biaryl linkage, usually biologically superior to those of their monomers. [8] Enzymes involved in biaryl natural product formation through oxidative phenol coupling have been reported; [9] however, the exact enzymatic reaction catalyzing this regioselective oxidative carbon-carbon coupling reaction is poorly understood. The aims of this study are to elucidate the biosynthetic pathway of 1, and to delineate the enzymology of the exciting chemical transformations of the aforementioned unique structural characteristics.…”
mentioning
confidence: 99%